Dr. Levin is an international opinion leader in creating a transformational change in the application of evidence to drive impactful innovation and guide it along the pathway to adoption. He is the Founder and Chief Executive and Scientific Officer of EXCITE International.
In 2011, Dr Levin initiated the first comprehensive collaborative premarket evaluation program, MaRS EXCITE, at MaRS Development District in Toronto to drive innovation to adoption. This program is currently evaluating 11 new technologies. Based on the success of MaRS EXCITE, in 2014 he founded EXCITE International which was recently incorporated as an non-profit independent organization to expedite adoption of new impactful technologies globally. EXCITE International represents a collaboration between USA, UK, Canada and the Netherlands and is growing to include other jurisdictions
Dr Levin was seconded into the Ontario Ministry of Health and Long-Term Care (MOHLTC) in 2000 where he was a member of Senior Management and reported to the Deputy Minister of Health. The evidence unit he developed and led informed policy decisions especially related to non-medical technologies and chronic disease management. In 2011, Dr. Levin was appointed VP of Health Quality Ontario’s (HQO’s) Evidence Development and Standards (EDS) division, a position he held until 2014. He has, since then focused exclusively on a collaborative approach to premarket evidence development that uses evidence to drive the innovation of impactful new medical technologies across the continuum from innovation to evaluation, regulation and adoption through single harmonized studies
In 2002, Dr Levin created the Ontario Health Technology Advisory Committee (OHTAC), which continues to provide evidence based advice to government and the health system on adoption of non-drug health technologies and broader health system change through a transparent, objective and collaborative initiative representing key health system stakeholders
Chief Executive Officer & Scientific Officer
MB, MD (Birm), FRCP (Lon), FRCPC Chief Scientific Officer of MaRS EXCITE
Dr Levin is a senior consultant in Medical Oncology at the Princess Margaret Hospital and is a Professor of Medicine at the University of Toronto. He received his medical degree and a research degree from the University of Birmingham (UK), the latter being based on research in cancer immunology. He has participated in numerous cancer related clinical trials, published over 60 original papers and made numerous presentations at national and international meetings.
Recent awards include the Excellence through Evidence award from the Canadian Health Services Research Foundation in 2013, the 2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Anniversary Medal, and the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Distinguished Service Award in 2014